Risk of Vulvar Squamous Cell Carcinoma in Women with Vulvar Lichen Planus: A Systematic Review

Authors

  • Astha Pant
  • Garima Singh
  • Amar Singh

Keywords:

vulvar lichen planus, vulvar squamous cell carcinoma, high grade squamous intraepithelial lesion, vulvar intraepithelial neoplasia, human papillomavirus independent carcinogenesis, systematic review

Abstract

This systematic review evaluated whether vulvar lichen planus is associated with malignant change and clarified clinical and biological modifiers of risk. Searches of major medical databases from 2010 to 2025 identified observational cohorts, clinicopathologic series, case–control studies, and case series with at least five participants. Two reviewers independently screened records extracted data on study characteristics, vulvar lichen planus definition, outcome ascertainment, biomarker status, and follow-up, and appraised methodological quality with standard tools. The primary outcome was invasive vulvar squamous cell carcinoma; secondary outcomes included high grade squamous intraepithelial lesion, vulvar intraepithelial neoplasia, time to transformation, and human papillomavirus or surrogate biomarker status. Fifteen studies met eligibility. Direct reports of invasive cancer among women with vulvar lichen planus were present but uncommon and derived mainly from retrospective cohorts and clinicopathologic series; additional signals arose from high grade squamous intraepithelial lesion and vulvar intraepithelial neoplasia, particularly within erosive disease. Clinicopathologic and biomarker findings supported a human papillomavirus independent pathway in many cases, with a possible human papillomavirus associated subset. Certainty was limited by small samples, heterogeneous definitions, and incomplete reporting. Overall, vulvar lichen planus appears to carry a non-zero malignant risk that justifies standardized diagnosis, structured surveillance, timely biopsy of non-healing change, and prospective site-specific research to refine absolute risk and pathway attribution.

Downloads

Download data is not yet available.

References

Eisen, D. (1994). The vulvovaginal-gingival syndrome of lichen planus: the clinical characteristics of 22 patients. Archives of Dermatology, 130(11), 1379-1382.

Ramos-e-Silva, M., Jacques, C. D. M. C., & da Silva Carneiro, S. C. (2010). Premalignant nature of oral and vulval lichen planus: facts and controversies. Clinics in dermatology, 28(5), 563-567.

Bleeker, M. C., Visser, P. J., Overbeek, L. I., van Beurden, M., & Berkhof, J. (2016). Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer epidemiology, biomarkers & prevention, 25(8), 1224-1230.

Vieira-Baptista, P., Pérez-López, F. R., López-Baena, M. T., Stockdale, C. K., Preti, M., & Bornstein, J. (2022). Risk of development of vulvar cancer in women with lichen sclerosus or lichen planus: a systematic review. Journal of lower genital tract disease, 26(3), 250-257.

Sadalla, J. C., Lourenço, S. V., Sotto, M. N., Baracat, E. C., & Carvalho, J. P. (2011). Claudin and p53 expression in vulvar lichen sclerosus and squamous-cell carcinoma. Journal of clinical pathology, 64(10), 853-857.

Liu, Y. A., Ji, J. X., Almadani, N., Crawford, R. I., Gilks, C. B., Kinloch, M., & Hoang, L. (2021). Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva. Histopathology, 78(3), 424-433.

Micheletti, L., Preti, M., Radici, G., Boveri, S., Di Pumpo, O., Privitera, S. S., & Benedetto, C. (2016). Vulvar lichen sclerosus and neoplastic transformation: a retrospective study of 976 cases. Journal of Lower Genital Tract Disease, 20(2), 180-183.

Aidé, S., Lattario, F. R., Almeida, G., do Val, I. C., & Carvalho, M. D. G. C. (2012). Promoter hypermethylation of death-associated protein kinase and p16 genes in vulvar lichen sclerosus. Journal of Lower Genital Tract Disease, 16(2), 133-139.

Eva, L., Sadler, L., Thompson, J. M., Sahota, S., Fong, K. L., Jones, R. W., & Bigby, S. M. (2022). HPV-independent and HPV-associated vulvar squamous cell carcinoma: two different cancers. International Journal of Gynecological Cancer, 32(9), 1108-1114.

Rakislova, N., Alemany, L., Clavero, O., Del Pino, M., Saco, A., Quirós, B., ... & Ordi, J. (2018). Differentiated vulvar intraepithelial neoplasia-like and lichen sclerosus-like lesions in HPV-associated squamous cell carcinomas of the vulva. The American Journal of Surgical Pathology, 42(6), 828-835.

Kherlopian A, Fischer G. Vulvar malignancy in biopsy-proven vulval lichen planus: a retrospective review of 105 cases. Australas J Dermatol. 2020;61(4):e427-30. doi:10.1111/ajd.13297

Kherlopian A, Fischer G. Identifying predictors of systemic immunosuppressive treatment of vulvovaginal lichen planus: a retrospective cohort study of 122 women. Australas J Dermatol. 2022;63(3):335-43. doi:10.1111/ajd.13803

Lyra J, Melo C, Figueiredo R, Polonia-Valente R, Falcão V, Beires J, et al. Erosive vulvar lichen planus and risk of vulvar neoplasia. J Low Genit Tract Dis. 2021;25(1):71-5. doi:10.1097/LGT.0000000000000580

Halonen P, Jakobsson M, Heikinheimo O, Riska A, Gissler M, Pukkala E. Cancer risk of lichen planus: a cohort study of 13,100 women in Finland. Int J Cancer. 2018;142(1):18-22. doi:10.1002/ijc.31011

Preti M, Micheletti L, Privitera S, Radici G, Gallio N, Benedetto C, et al. Vulvar lichen planus: a risk factor for vulvar high-grade squamous intraepithelial lesion recurrence? J Low Genit Tract Dis. 2018;22(3):264-5. doi:10.1097/LGT.0000000000000410

Kaderly Rasmussen EL, Hannibal CG, Hertzum-Larsen R, Kjær SK, Baandrup L. Biopsy-verified vulvar lichen sclerosus and the risk of non-vulvar cancer: a nationwide cohort study. Int J Cancer. 2024;155(10):1714-20. doi:10.1002/ijc.34844

Gulin SJ, Lundin F, Seifert O. Comorbidity in patients with lichen sclerosus: a retrospective cohort study. Eur J Med Res. 2023;28(1):338. doi:10.1186/s40001-023-01354-0

Santegoets LA, Helmerhorst TJ, van der Meijden WI. A retrospective study of 95 women with a clinical diagnosis of genital lichen planus. J Low Genit Tract Dis. 2010;14(4):323-8. doi:10.1097/LGT.0b013e3181d39e74

Simpson RC, Littlewood SM, Cooper SM, Cruickshank ME, Green CM, Derrick E, et al. Real-life experience of managing vulval erosive lichen planus: a case-based review and UK multicentre case note audit. Br J Dermatol. 2012;167(1):85-91. doi:10.1111/j.1365-2133.2012.10906.x

Regauer S, Eberz B, Reich O. Human papillomavirus–induced squamous intraepithelial lesions in vulvar lichen planus. J Low Genit Tract Dis. 2016;20(4):360-4. doi:10.1097/LGT.0000000000000240

Regauer S, Reich O, Eberz B. Vulvar cancers in women with vulvar lichen planus: a clinicopathological study. J Am Acad Dermatol. 2014;71(4):698-707. doi:10.1016/j.jaad.2014.05.016

Fahy CM, Torgerson RR, Davis MD. Lichen planus affecting the female genitalia: a retrospective review of patients at Mayo Clinic. J Am Acad Dermatol. 2017;77(6):1053-9. doi:10.1016/j.jaad.2017.07.010

Day T, Otton G, Jaaback K, Weigner J, Scurry J. Is vulvovaginal lichen planus associated with squamous cell carcinoma? J Low Genit Tract Dis. 2018;22(2):159-65. doi:10.1097/LGT.0000000000000387

Danielsson K, Olah J, Zohori-Zangeneh R, Nylander E, Ebrahimi M. Increased expression of p16 in both oral and genital lichen planus. Med Oral Patol Oral Cir Bucal. 2018;23(4):e449-54. doi:10.4317/medoral.22354

Rolfe KJ, Eva LJ, MacLean AB, Crow JC, Perrett CW, Reid WMN. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer. 2001;11(2):113-8. doi:10.1046/j.1525-1438.2001.011002113.x

Leis M, Singh A, Li C, Ahluwalia R, Fleming P, Lynde CW. Risk of vulvar squamous cell carcinoma in lichen sclerosus and lichen planus: a systematic review. J Obstet Gynaecol Can. 2022;44(2):182-92. doi:10.1016/j.jogc.2021.06.007

Gupta S, Ahuja S, Kalwaniya DS, Shamsunder S, Solanki S. Vulval premalignant lesions: a review article. Obstet Gynecol Sci. 2024;67(2):169-85. doi:10.5468/ogs.23225

Hieta NK, Tapana L, Söderlund JM, Huvila JK, Talve LA, Haataja MA. Risk of vulvar HSIL and penile neoplasias in anogenital lichen planus: a case-control study. J Low Genit Tract Dis. 2025;29(3):288-92. doi:10.1097/LGT.0000000000000771

Lin A, Day T, Ius Y, Scurry J. Anogenital high-grade squamous intraepithelial lesion comorbid with vulvar lichen sclerosus and lichen planus. J Low Genit Tract Dis. 2020;24(3):311-6. doi:10.1097/LGT.0000000000000552

Wu M, Lee G, Fischer G. Forming diagnostic criteria for vulvar lichen planus. Australas J Dermatol. 2020;61(4):324-9. doi:10.1111/ajd.13307

Pouwer AFW, Van den Einden LC, Van der Linden M, Hehir-Kwa JY, Yu J, Hendriks KM, et al. Clonal relationship between lichen sclerosus, differentiated vulvar intraepithelial neoplasia and non-HPV-related vulvar squamous cell carcinoma. Cancer Genomics Proteomics. 2020;17(2):151-60. doi:10.21873/cgp.20176

Shen ZY, Liu W, Feng JQ, Zhou HW, Zhou ZT. Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(5):592-6. doi:10.1016/j.tripleo.2011.05.034

Xie F, Dasari S, Deschaine M, Gleue CA, Sartori-Valinotti JC, Torgerson RR, et al. Differential proteomic expression profiles in vulvar lichen planus as compared to normal vulvar tissue, vulvar lichen sclerosus, or oral lichen planus: an exploratory study. Exp Dermatol. 2023;32(9):1498-508. doi:10.1111/exd.14877

Giuliani M, Troiano G, Cordaro M, Corsalini M, Gioco G, Lo Muzio L, et al. Rate of malignant transformation of oral lichen planus: a systematic review. Oral Dis. 2019;25(3):693-709. doi:10.1111/odi.12885

van de Nieuwenhof HP. Lichen sclerosus and vulvar intraepithelial neoplasia in vulvar cancer: towards the identification of a true premalignant lesion [thesis]. Nijmegen: Radboud University; 2010.

Chin S, Scurry J, Bradford J, Lee G, Fischer G. Association of topical corticosteroids with reduced vulvar squamous cell carcinoma recurrence in patients with vulvar lichen sclerosus. JAMA Dermatol. 2020;156(7):813-4. doi:10.1001/jamadermatol.2020.0865

Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP. Association between topical calcineurin inhibitor use and keratinocyte carcinoma risk among adults with atopic dermatitis. JAMA Dermatol. 2020;156(10):1066-73. doi:10.1001/jamadermatol.2020.2219

Singh N, Ghatage P. Etiology, clinical features, and diagnosis of vulvar lichen sclerosus: a scoping review. Obstet Gynecol Int. 2020;2020:7480754. doi:10.1155/2020/7480754

Cebolla-Verdugo M, Cassini-Gómez de Cádiz VA, Velasco-Amador JP, Zulaika-Lloret M, Almazán-Fernández FM, Ruiz-Villaverde R. Multidisciplinary vulvar cancer management: the dermatologist’s perspective. Life (Basel). 2024;15(1):19. doi:10.3390/life15010019

Downloads

Published

2025-09-25

How to Cite

1.
Pant A, Singh G, Singh A. Risk of Vulvar Squamous Cell Carcinoma in Women with Vulvar Lichen Planus: A Systematic Review. J Neonatal Surg [Internet]. 2025Sep.25 [cited 2025Oct.1];13(1):1310-21. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/9232

Issue

Section

Original Article